KTOS lands billion-dollar hypersonics deal as AXON rides TASER and body cam growth, but rising costs cloud its outlook.

KTOS lands billion-dollar hypersonics deal as AXON rides TASER and body cam growth, but rising costs cloud its outlook.

Can DECK sustain its strong operating margins in fiscal 2026 as tariff and logistics pressures begin to mount?

Can DECK sustain its strong operating margins in fiscal 2026 as tariff and logistics pressures begin to mount?

Intuitive Surgical raises 2025 procedure outlook after strong Q1 growth, but rising costs and tariff pressure weigh on margins.

TOST stock surges on 25% revenue growth and 32% EBITDA margin. It raises 2025 outlook as it scales with disciplined cost control.

TOST stock surges on 25% revenue growth and 32% EBITDA margin. It raises 2025 outlook as it scales with disciplined cost control.

Boston Scientific lifts its 2025 sales and EPS outlook after a strong Q1, with cardiology and EP segments fueling major gains.

Post Holdings lifts fiscal 2025 EBITDA guidance, leaning on pricing and supply-chain execution amid weak demand and egg cost recovery.

Post Holdings lifts fiscal 2025 EBITDA guidance, leaning on pricing and supply-chain execution amid weak demand and egg cost recovery.